v3.26.1
Segment Reporting - Schedule of Reconciliation of Adjusted EBITDA (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Line Items]        
Revenue [1] $ 652,520 $ 444,328 $ 1,148,766 $ 927,977
Depreciation and amortization expenses 21,566 23,141 43,121 47,199
Interest income (703) (1,084) (1,717) (2,358)
Interest expense 16,859 11,601 33,727 21,986
Gain (loss) from equity method investees 41 (197) 52 (178)
Provision for (benefit from) income taxes 2,715 (825) 3,625 645
Net loss attributable to common shareholders of Evolent Health, Inc. - basic (28,364) (51,090) (54,996) (123,340)
Net loss attributable to common shareholders of Evolent Health, Inc. - diluted (28,364) (51,090) (54,996) (123,340)
Total claims incurred     763,297 420,239
Total compensation expense by financial statement line item 15,201 11,580 25,850 22,661
Severance and termination benefits        
Segment Reporting [Line Items]        
Severance costs 275 791 275 1,805
Income Statement Location [Axis]: us-gaap:CostOfRevenue        
Segment Reporting [Line Items]        
Total compensation expense by financial statement line item 695 1,050 1,214 1,707
Income Statement Location [Axis]: us-gaap:CostsAndExpenses        
Segment Reporting [Line Items]        
Total compensation expense by financial statement line item 700 1,000 1,200 1,700
Income Statement Location [Axis]: us-gaap:SellingGeneralAndAdministrativeExpense        
Segment Reporting [Line Items]        
Total compensation expense by financial statement line item 14,506 10,530 24,636 20,954
Transaction-related costs 569 0 1,031 703
Reportable segment        
Segment Reporting [Line Items]        
Revenue 652,520 444,328 1,148,766 927,977
Medical expense and device costs 493,023 249,161 828,385 541,838
Cost of revenue excluding medical expense and device costs and other segment items 77,966 93,732 154,557 181,576
Selling, general and administrative expenses excluding other segment items 53,481 63,888 115,707 130,156
Depreciation and amortization expenses 21,566 23,141 43,121 47,199
Interest income (703) (1,084) (1,717) (2,358)
Interest expense 16,859 11,601 33,727 21,986
Gain (loss) from equity method investees 41 (197) 52 (178)
Provision for (benefit from) income taxes 2,715 (825) 3,625 645
Other segment items 15,936 56,001 26,305 130,453
Net loss attributable to common shareholders of Evolent Health, Inc. - basic (28,364) (51,090) (54,996) (123,340)
Net loss attributable to common shareholders of Evolent Health, Inc. - diluted (28,364) (51,090) (54,996) (123,340)
Total claims incurred $ 461,500 $ 214,200 $ 763,300 $ 420,200
[1] See Note 17 for amounts attributable to unconsolidated related parties included in these line items.